Briviact
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50474-770 -
Package NDC
50474-770-09 -
Package NDC
50474-770-14 -
Package NDC
50474-770-66 -
Application number
NDA205836 -
SPL ID
5f8da779-3d40-7790-e063-6394a90af1e7 -
SPL set ID
3cf2f439-0e97-443e-8e33-25ecef616f6c -
UNII
U863JGG2IA -
RxCUI
1739749 -
RxCUI
1739754 -
RxCUI
1739761 -
RxCUI
1739766 -
RxCUI
1739768 -
RxCUI
1739770 -
RxCUI
1739772 -
RxCUI
1739774 -
RxCUI
1739776 -
RxCUI
1739778 -
RxCUI
1739780 -
RxCUI
1739782 -
RxCUI
1739785 -
RxCUI
1739788
What the source publishes
- Labeler
- UCB, Inc.
- Active ingredients
- brivaracetam
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Briviact",
"splId": "5f8da779-3d40-7790-e063-6394a90af1e7",
"labels": [
{
"setId": "3cf2f439-0e97-443e-8e33-25ecef616f6c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3cf2f439-0e97-443e-8e33-25ecef616f6c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cf2f439-0e97-443e-8e33-25ecef616f6c"
}
],
"routes": [
"ORAL"
],
"labeler": "UCB, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "50474-770-09",
"identifierStatus": "well-formed",
"marketing_end_date": "20301129",
"marketing_start_date": "20160512"
},
{
"sample": true,
"description": "1 BLISTER PACK in 1 CARTON (50474-770-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "50474-770-14",
"identifierStatus": "well-formed",
"marketing_start_date": "20160512"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (50474-770-66) / 60 TABLET, FILM COATED in 1 BOTTLE",
"package_ndc": "50474-770-66",
"identifierStatus": "well-formed",
"marketing_start_date": "20160512"
}
],
"productId": "50474-770_5f8da779-3d40-7790-e063-6394a90af1e7",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "50474-770",
"deaSchedule": "CV",
"genericName": "brivaracetam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BRIVARACETAM",
"strength": "100 mg/1"
}
],
"applicationNumber": "NDA205836",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160512",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192345"
],
"unii": [
"U863JGG2IA"
],
"rxcui": [
"1739749",
"1739754",
"1739761",
"1739766",
"1739768",
"1739770",
"1739772",
"1739774",
"1739776",
"1739778",
"1739780",
"1739782",
"1739785",
"1739788"
],
"spl_set_id": [
"3cf2f439-0e97-443e-8e33-25ecef616f6c"
],
"pharm_class_moa": [
"Epoxide Hydrolase Inhibitors [MoA]"
],
"manufacturer_name": [
"UCB, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50474-770_5f8da779-3d40-7790-e063-6394a90af1e7"